4//SEC Filing
Radoff Bradley Louis 4
Accession 0001213900-25-078744
CIK 0000316253other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 8:31 AM ET
Size
7.9 KB
Accession
0001213900-25-078744
Insider Transaction Report
Form 4
ENZO BIOCHEM INCENZB
Radoff Bradley Louis
Director
Transactions
- Disposition to Issuer
Common Stock
2025-08-20−430,000→ 0 total(indirect: By Foundation) - Disposition to Issuer
Common Stock
2025-08-20−4,533,779→ 0 total
Footnotes (3)
- [F1]The shares were disposed of pursuant to the Agreement and Plan of Merger, dated June 23, 2025 (the "Merger Agreement"), by and among the Issuer, Bethpage Parent, Inc. ("Parent"), and Bethpage Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), was canceled and automatically converted into the right to receive $0.70 in cash, without interest and less any applicable withholding taxes (the "Merger Consideration").
- [F2]Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") that vested solely on the basis of time that was outstanding as of immediately prior to the Effective Time and was held by a member of the Issuer's Board of Directors was canceled and converted into the right to receive an amount in cash obtained by multiplying (A) the total number of shares of Common Stock underlying such RSU, by (B) the Merger Consideration, subject to any required withholding of taxes.
- [F3]Represents 142,897 RSUs and 4,390,882 shares of Common Stock.
Documents
Issuer
ENZO BIOCHEM INC
CIK 0000316253
Entity typeother
Related Parties
1- filerCIK 0001380585
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 8:31 AM ET
- Size
- 7.9 KB